<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00129597</url>
  </required_header>
  <id_info>
    <org_study_id>2004.349</org_study_id>
    <nct_id>NCT00129597</nct_id>
  </id_info>
  <brief_title>Effect of Ketalar to Prevent Postoperative Chronic Pain After Mastectomy</brief_title>
  <official_title>Effect of Ketalar to Prevent Postoperative Chronic Pain After Mastectomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospices Civils de Lyon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospices Civils de Lyon</source>
  <brief_summary>
    <textblock>
      Prevalence of chronic pain after mastectomy is beyond 50% 3 months after surgery. This pain
      is related to a sensitization of the central nervous system through N-methyl-D-asparate
      (NMDA) receptors. Ketalar might prevent the occurrence of chronic pain by anti-NMDA
      properties after mastectomy.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>December 2004</start_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double</masking>
  </study_design_info>
  <primary_outcome>
    <measure>To evaluate the effect of perioperative ketalar on pain intensity 3 months after a mastectomy</measure>
  </primary_outcome>
  <primary_outcome>
    <measure>Pain intensity is evaluated by an appropriate questionnaire 1 and 3 months after surgery.</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>To evaluate the incidence of chronic pain after mastectomy, the impact on life quality, and the area of hyperalgesia</measure>
  </secondary_outcome>
  <enrollment>40</enrollment>
  <condition>Pain</condition>
  <condition>Breast Cancer</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>ketalar</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Mastectomy in patients 18 to 80 years old

        Exclusion Criteria:

          -  American Society of Anesthesiology (ASA) class &gt;= 3

          -  Renal, heart or hepatic failure

          -  Allergy to ketalar

          -  Psychiatric disease

          -  Chronic antalgic treatment
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Vincent PIRIOU, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospices Civils de Lyon</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Centre Hospitalier Lyon Sud</name>
      <address>
        <city>Pierre b√©nite</city>
        <zip>69495</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>March 2007</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 10, 2005</study_first_submitted>
  <study_first_submitted_qc>August 10, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 12, 2005</study_first_posted>
  <last_update_submitted>March 9, 2007</last_update_submitted>
  <last_update_submitted_qc>March 9, 2007</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 12, 2007</last_update_posted>
  <keyword>Ketalar</keyword>
  <keyword>NMDA</keyword>
  <keyword>mastectomy</keyword>
  <keyword>postoperative chronic pain</keyword>
  <keyword>Chronic pain after mastectomy for breast cancer</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Chronic Pain</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ketamine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

